Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of Type 2 diabetes and weight management
Trial completion and results are expected to provide efficacy and safety data in broader populations and longer treatment durations than Phase 2
These organisms express large quantities of rHGH in their cells
Topiramate, propranolol, and valproate significantly reduced migraine frequency, intensity, and duration, consistent with the 2019 European Headache Federation guidelines, which classify topiramate and propranolol as Level A recommendations and valproate as Level B (Sacco et al., 2019)
Ozempic, made by Novo Nordisk, remains the most popular, but Eli Lillys Mounjaro is gaining ground